journal article·2019-09-24Open access

Rapid On-Demand Extracellular Vesicle Augmentation with Versatile Oligonucleotide Tethers

Saigopalakrishna S. Yerneni, Sushil Lathwal, Pradeep Shrestha, Haval Shirwan, Krzysztof Matyjaszewski, Lee Weiss, Esma S. Yolcu, Phil G. Campbell, Subha R. Das

ACS Nano· Volume 13· Issue 9

Abstract

Exosomes show potential as ideal vehicles for drug delivery because of their natural role in transferring biological cargo between cells. However, current methods to engineer exosomes without negatively impacting their function remain challenging. Manipulating exosome-secreting cells is complex and time-consuming, while direct functionalization of exosome surface proteins suffers from low specificity and low efficiency. We demonstrate a rapid, versatile, and scalable method with oligonucleotide tethers to enable diverse surface functionalization on both human and murine exosomes. These exosome surface modifiers, which range from reactive functional groups and small molecules to aptamers and large proteins, can readily and efficiently enhance native exosome properties. We show that cellular uptake of exosomes can be specifically altered with a tethered AS1411 aptamer, and targeting specificity can be altered with a tethered protein. We functionalize exosomes with an immunomodulatory protein, FasL, and demonstrate their biological activity both in vitro and in vivo . FasL-functionalized exosomes, when bioprinted on a collagen matrix, allows spatial induction of apoptosis in tumor cells and, when injected in mice, suppresses proliferation of alloreactive T cells. This oligonucleotide tethering strategy is independent of the exosome source and further circumvents the need to genetically modify exosome-secreting cells.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · RNA Interference and Gene Delivery · MicroRNA in disease regulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, United States

Department of Chemistry, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, United States

Center for Nucleic Acids Science & Technology, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, United States

Institute for Cellular Therapeutics and Department of Microbiology and Immunology, University of Louisville, Louisville, Kentucky 40292, United States

The Robotics Institute, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, United States

Engineering Research Accelerator, Carnegie Mellon University, Pittsburgh, Pennsylvania 15213, United States

Funding

National Institute of Allergy and Infectious Diseases · Carnegie Mellon University

References (76)

Show source-provided references
1. 10.1146/annurev-cellbio-101512-12232610.1146/annurev-cellbio-101512-122326 ↗
2. 10.3402/jev.v4.2706610.3402/jev.v4.27066 ↗
3. 10.1016/j.jconrel.2011.11.02110.1016/j.jconrel.2011.11.021 ↗
4. 10.1146/annurev-pharmtox-010814-12463010.1146/annurev-pharmtox-010814-124630 ↗
5. 10.1021/acsnano.6b0760710.1021/acsnano.6b07607 ↗
6. 10.2147/IJN.S2966110.2147/IJN.S29661 ↗
7. 10.1016/j.jconrel.2014.07.04910.1016/j.jconrel.2014.07.049 ↗
8. 10.1038/nrd397810.1038/nrd3978 ↗
9. 10.3402/jev.v4.3008710.3402/jev.v4.30087 ↗
10. 10.1016/j.jconrel.2015.07.03010.1016/j.jconrel.2015.07.030 ↗
11. 10.1016/j.jconrel.2014.11.02910.1016/j.jconrel.2014.11.029 ↗
12. 10.1002/adma.20170661610.1002/adma.201706616 ↗
13. 10.4155/tde.11.8310.4155/tde.11.83 ↗
14. 10.1038/nbt.180710.1038/nbt.1807 ↗
15. 10.1038/ncomms228210.1038/ncomms2282 ↗
16. 10.1021/nn405724x10.1021/nn405724x ↗
17. 10.1038/mt.2012.18010.1038/mt.2012.180 ↗
18. 10.1002/mds.2597810.1002/mds.25978 ↗
19. 10.1016/j.biomaterials.2013.11.08310.1016/j.biomaterials.2013.11.083 ↗
20. 10.1016/j.jconrel.2016.01.00910.1016/j.jconrel.2016.01.009 ↗
21. 10.3402/jev.v3.2464110.3402/jev.v3.24641 ↗
22. 10.1021/bc500291r10.1021/bc500291r ↗
23. 10.1080/20013078.2018.144013110.1080/20013078.2018.1440131 ↗
24. 10.1016/j.addr.2018.06.01710.1016/j.addr.2018.06.017 ↗
25. 10.1016/j.ymthe.2017.03.02110.1016/j.ymthe.2017.03.021 ↗
26. 10.1038/mt.2016.12610.1038/mt.2016.126 ↗
27. 10.1126/scitranslmed.aat019510.1126/scitranslmed.aat0195 ↗
28. 10.1073/pnas.130426611010.1073/pnas.1304266110 ↗
29. 10.1007/s12257-015-0781-x10.1007/s12257-015-0781-x ↗
30. 10.1158/1541-7786.MCR-18-035810.1158/1541-7786.MCR-18-0358 ↗
31. 10.1016/j.yexmp.2009.01.00410.1016/j.yexmp.2009.01.004 ↗
32. 10.18632/oncotarget.707310.18632/oncotarget.7073 ↗
33. 10.1016/j.omtn.2018.06.00310.1016/j.omtn.2018.06.003 ↗
34. 10.1016/j.talanta.2013.09.06210.1016/j.talanta.2013.09.062 ↗
35. 10.1158/1078-0432.CCR-17-266410.1158/1078-0432.CCR-17-2664 ↗
36. 10.1038/s41598-017-14661-w10.1038/s41598-017-14661-w ↗
37. 10.1046/j.1440-1711.2002.01068.x10.1046/j.1440-1711.2002.01068.x ↗
38. 10.1016/S1074-7613(02)00482-X10.1016/S1074-7613(02)00482-X ↗
39. 10.1038/cdd.2015.310.1038/cdd.2015.3 ↗
40. 10.1038/s41563-018-0099-010.1038/s41563-018-0099-0 ↗
41. 10.1517/14712598.7.8.112310.1517/14712598.7.8.1123 ↗
42. 10.1634/stemcells.2007-052010.1634/stemcells.2007-0520 ↗
43. 10.1016/j.biomaterials.2005.10.02110.1016/j.biomaterials.2005.10.021 ↗
44. 10.1002/jor.2383310.1002/jor.23833 ↗
45. 10.2337/db16-032010.2337/db16-0320 ↗
46. 10.1016/j.bprint.2019.e0004110.1016/j.bprint.2019.e00041 ↗
47. 10.1016/j.biomaterials.2005.04.03210.1016/j.biomaterials.2005.04.032 ↗
48. 10.4049/jimmunol.181.2.93110.4049/jimmunol.181.2.931 ↗
49. 10.4049/jimmunol.100326610.4049/jimmunol.1003266 ↗
50. 10.1021/ja048514b10.1021/ja048514b ↗
51. 10.1021/ja208094910.1021/ja2080949 ↗
52. 10.1021/bm501467h10.1021/bm501467h ↗
53. 10.1038/nnano.2017.2310.1038/nnano.2017.23 ↗
54. 10.1021/ja710644g10.1021/ja710644g ↗
55. 10.1038/nnano.2009.8310.1038/nnano.2009.83 ↗
56. 10.1038/nnano.2015.13010.1038/nnano.2015.130 ↗
57. 10.1038/s41565-017-0012-z10.1038/s41565-017-0012-z ↗
58. 10.1021/ja504845f10.1021/ja504845f ↗
59. 10.1021/acs.analchem.7b0391910.1021/acs.analchem.7b03919 ↗
60. 10.1194/jlr.R08434310.1194/jlr.R084343 ↗
61. 10.1042/bj2003159410.1042/bj20031594 ↗
62. 10.1038/nrd163210.1038/nrd1632 ↗
63. 10.1016/j.addr.2012.09.03710.1016/j.addr.2012.09.037 ↗
64. 10.3389/fphar.2015.0028610.3389/fphar.2015.00286 ↗
65. 10.1080/10717544.2016.117713610.1080/10717544.2016.1177136 ↗
66. 10.1016/j.addr.2018.10.01210.1016/j.addr.2018.10.012 ↗
67. 10.1016/j.nantod.2015.04.00410.1016/j.nantod.2015.04.004 ↗
68. 10.1158/1078-0432.CCR-16-281910.1158/1078-0432.CCR-16-2819 ↗
69. 10.3389/fimmu.2015.0012210.3389/fimmu.2015.00122 ↗
70. 10.1016/j.vaccine.2011.09.13310.1016/j.vaccine.2011.09.133 ↗
71. 10.4049/jimmunol.172.4.212610.4049/jimmunol.172.4.2126 ↗
72. 10.1182/blood-2004-06-236410.1182/blood-2004-06-2364 ↗
73. 10.1161/01.CIR.0000064893.96179.7E10.1161/01.CIR.0000064893.96179.7E ↗
74. 10.1196/annals.1352.03610.1196/annals.1352.036 ↗
75. 10.1002/smll.20170290910.1002/smll.201702909 ↗
76. Theodoraki M.-N. · Oncoscience · 2018 · 5 · 7510.18632/oncoscience.410 ↗